Literature DB >> 3269515

Disparity-induced accommodation in late-onset myopia.

M Rosenfield1, B Gilmartin.   

Abstract

The effect of disparity-vergence on the accommodation response (AR) was measured in 10 late-onset myopes (LOMs) and 10 emmetropic subjects during the course of a 10 minute near-vision task (working distance 33 cm). Disparity was induced by the introduction of 3 and 6 delta base-out prisms placed before the right eye, and the resulting AR for the left eye was measured at 1 min intervals using an objective infra-red optometer. LOMs showed a significant increase in AR with increasing disparity whereas emmetropes showed no significant difference in AR for all disparity conditions. The implications of these findings are discussed with reference to the aetiology of late-onset myopia.

Entities:  

Mesh:

Year:  1988        PMID: 3269515

Source DB:  PubMed          Journal:  Ophthalmic Physiol Opt        ISSN: 0275-5408            Impact factor:   3.117


  5 in total

Review 1.  Clinical and laboratory investigations of the relationship of accommodation and convergence function with refractive error. A literature review.

Authors:  D A Goss; H Zhai
Journal:  Doc Ophthalmol       Date:  1994       Impact factor: 2.379

2.  Accommodation and induced myopia in marmosets.

Authors:  David Troilo; Nicole Quinn; Kayla Baker
Journal:  Vision Res       Date:  2007-03-13       Impact factor: 1.886

3.  Effect of Vision Therapy on Accommodation in Myopic Chinese Children.

Authors:  Martin Ming-Leung Ma; Mitchell Scheiman; Cuiyun Su; Xiang Chen
Journal:  J Ophthalmol       Date:  2016-12-21       Impact factor: 1.909

4.  Influence of Near Tasks on Posture in Myopic Chinese Schoolchildren.

Authors:  Jinhua Bao; Björn Drobe; Yuwen Wang; Ke Chen; Eu Jin Seow; Fan Lu
Journal:  Optom Vis Sci       Date:  2015-08       Impact factor: 1.973

5.  Axial Elongation During Short-Term Accommodation in Myopic and Nonmyopic Children.

Authors:  Rohan P J Hughes; Scott A Read; Michael J Collins; Stephen J Vincent
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-03-02       Impact factor: 4.799

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.